This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1992 Nov 7;340(8828):1145-7.

doi: 10.1016/0140-6736(92)93162-g.

The case for clinical trials of tamoxifen for prevention of breast cancer

T J Powles¹

Affiliations

PMID: 1359221
DOI: 10.1016/0140-6736(92)93162-g

Clinical Trial

The case for clinical trials of tamoxifen for prevention of breast cancer

T J Powles. Lancet. 1992.

. 1992 Nov 7;340(8828):1145-7.

doi: 10.1016/0140-6736(92)93162-g.

Author

T J Powles¹

Affiliation

¹ Breast Unit, Royal Marsden Hospital, London, UK.

PMID: 1359221
DOI: 10.1016/0140-6736(92)93162-g

No abstract available

PubMed Disclaimer

Comment in

Prevention of breast cancer.
Neven P, Lowe DG, Shepherd JH. Neven P, et al. Lancet. 1992 Dec 19-26;340(8834-8835):1551. Lancet. 1992. PMID: 1361641 No abstract available.
Prevention of breast cancer.
Nicholson RH. Nicholson RH. Lancet. 1992 Dec 19-26;340(8834-8835):1551-2. Lancet. 1992. PMID: 1361643 No abstract available.

Similar articles

Tamoxifen for breast cancer prevention.
Jordan VC. Jordan VC. Proc Soc Exp Biol Med. 1995 Feb;208(2):144-9. doi: 10.3181/00379727-208-43846c. Proc Soc Exp Biol Med. 1995. PMID: 7831346 Review. No abstract available.
Tamoxifen for the prevention of breast cancer: no.
DeGregorio MW, Maenpaa JU, Wiebe VJ. DeGregorio MW, et al. Important Adv Oncol. 1995:175-85. Important Adv Oncol. 1995. PMID: 7672804 Review.
Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers.
Cook LS, Weiss NS, Schwartz SM, White E, McKnight B, Moore DE, Daling JR. Cook LS, et al. J Natl Cancer Inst. 1995 Sep 20;87(18):1359-64. doi: 10.1093/jnci/87.18.1359. J Natl Cancer Inst. 1995. PMID: 7658496
Re: tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
Love RR. Love RR. J Natl Cancer Inst. 1999 Nov 3;91(21):1891-2. doi: 10.1093/jnci/91.21.1891. J Natl Cancer Inst. 1999. PMID: 10547398 No abstract available.
Breast cancer prevention trial will resume.
Smigel K, Ulbrich S. Smigel K, et al. J Natl Cancer Inst. 1994 Jul 6;86(13):961-3. doi: 10.1093/jnci/86.13.961. J Natl Cancer Inst. 1994. PMID: 8007016 No abstract available.

See all similar articles

Cited by

Phase I study of percutaneous 4-hydroxy-tamoxifen with analyses of 4-hydroxy-tamoxifen concentrations in breast cancer and normal breast tissue.
Pujol H, Girault J, Rouanet P, Fournier S, Grenier J, Simony J, Fourtillan JB, Pujol JL. Pujol H, et al. Cancer Chemother Pharmacol. 1995;36(6):493-8. doi: 10.1007/BF00685799. Cancer Chemother Pharmacol. 1995. PMID: 7554041 Clinical Trial.
Natural killer cell activity, phagocytosis, and number of peripheral blood cells in breast cancer patients treated with tamoxifen.
Lukac J, Kusić Z, Kordić D, Koncar M, Bolanca A. Lukac J, et al. Breast Cancer Res Treat. 1994;29(3):279-85. doi: 10.1007/BF00666482. Breast Cancer Res Treat. 1994. PMID: 8049462
Antioxidant benefits of tamoxifen therapy for breast cancer?
Wiseman H, Rice-Evans C, Halliwell B. Wiseman H, et al. Breast Cancer Res Treat. 1994;29(3):307. doi: 10.1007/BF00666485. Breast Cancer Res Treat. 1994. PMID: 8049464 No abstract available.
The Royal Marsden Hospital pilot tamoxifen chemoprevention trial.
Powles TJ, Jones AL, Ashley SE, O'Brien ME, Tidy VA, Treleavan J, Cosgrove D, Nash AG, Sacks N, Baum M, et al. Powles TJ, et al. Breast Cancer Res Treat. 1994;31(1):73-82. doi: 10.1007/BF00689678. Breast Cancer Res Treat. 1994. PMID: 7981459 Clinical Trial.
Tamoxifen: a review of pharmacoeconomic and quality-of-life considerations for its use as adjuvant therapy in women with breast cancer.
Bryson HM, Plosker GL. Bryson HM, et al. Pharmacoeconomics. 1993 Jul;4(1):40-66. doi: 10.2165/00019053-199304010-00006. Pharmacoeconomics. 1993. PMID: 10146967 Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information